# Low Pain Prediction in Cesarean Section Patients

> **NCT02143141** · PHASE4 · TERMINATED · sponsor: **Wake Forest University Health Sciences** · enrollment: 13 (actual)

## Conditions studied

- Scheduled Cesarean Sections
- Postoperative Pain Management
- Side Effects

## Interventions

- **DRUG:** duramorph
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02143141
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-11
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** feasibility of population needed to complete study
- **Last updated:** 2018-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02143141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02143141, "Low Pain Prediction in Cesarean Section Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02143141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*